Global Endometrial Ablation Devices Market, By Device Type (Hysteroscopy devices, Thermal balloon ablators, Radiofrequency endometrial ablation devices, Hydrothermal ablators, Electrical ablators, Others), End-Use (Hospitals, Clinics, Ambulatory Surgical Centres, Others) – Industry Trends and Forecast to 2030.
Endometrial Ablation Devices Market Analysis and Size
According to the study titled "Radiofrequency endometrial ablation with a novel endometrial tip for the management of heavy menstrual bleeding and abnormal uterine bleeding: a prospective study," published in July 2020, the safety and efficacy of a radiofrequency ablation system with a new endometrial tip (RFA-EMT) for heavy menstrual bleeding (HMB) or abnormal uterine bleeding (AUB) were 97.4% and 100%, respectively. Thus, the increased safety and efficacy of the radiofrequency ablation system is expected to drive segment growth during the forecast period.
Data Bridge Market Research analyses that the endometrial ablation devices market which is USD 3.46 billion in 2022, is expected to reach USD 5.56 billion by 2030, at a CAGR of 6.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Endometrial Ablation Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Device Type (Hysteroscopy devices, Thermal balloon ablators, Radiofrequency endometrial ablation devices, Hydrothermal ablators, Electrical ablators, Others), End-Use (Hospitals, Clinics, Ambulatory Surgical Centres, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
AEGEA Medical, Inc (U.S.), Boston Scientific Corporation (U.S.), CooperSurgical, Inc (U.S.), Hologic, Inc. (U.S.), IDOMAN-MED (Canada), Minerva Surgical, Inc (U.S.), Olympus Corporation (Japan), Omnitech Systems, Inc (U.S.) and Medtronic (Ireland)
|
|
Market Opportunities
|
|
Market Definition
Endometrial ablation is a medical procedure that allows for the removal of endometrium from the uterine wall. Endometrium ablation aids in the destruction of such thin layers to stop abnormal heavy uterine bleeding, and it is highly recommended when uterine bleeding is no longer controlled by medications.
Endometrial Ablation Devices Market Dynamics
Drivers
- Rise in the prevalence of gynaecological disorders
The rise in the prevalence of gynaecological disorders such as cervical cancer, menorrhagia, abnormal vaginal bleeding, and POCD (polycystic ovarian disease) in women is a major factor driving market growth. Cervical cancer is the fourth most common cancer in women worldwide, according to World Health Organization Updates in February 2022, with 604 000 new cases and 342 000 deaths by 2020. Low- and middle-income countries will account for nearly 90% of new cases and deaths globally by 2020. As a result, the increasing prevalence of gynaecological diseases is expected to drive market growth during the forecast period.
- Rising prevalence of endometrial cancer
The rising prevalence of endometrial cancer is expected to drive segment expansion. According to the American Cancer Society's 2022 update, more than 600,000 endometrial cancer survivors are in the United States. According to the same source, approximately 65,950 new cases of cancer of the uterine body (uterine body or corpus) are expected to be diagnosed in 2022. As a result of the increasing prevalence of endometrial cancer, demand for endometrial ablation devices is expected to rise.
Opportunities
- Rising technological developments
The increasing developments made by the key players in the ablation segment are also contributing to the market's growth. For instance, on Tuesday at the 50th Global Congress of the American Association of Gynecologic Laparoscopists (AAGL), Hologic, Inc. unveiled the NovaSure V5 global endometrial ablation (GEA) device in November 2021. .
Restraints/Challenges
- Risks associated with endometrial ablation
Risk associated with endometrial ablation is the most significant factor among others acting as restraints, and it will further challenge the growth of the endometrial ablation devices market during the forecast period.
This endometrial ablation devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the endometrial ablation devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Endometrial Ablation Devices Market
The healthcare sector has faced significant challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or limited to reduce the risk of viral transmission, because most chronic therapies were deemed non-urgent during the COVID-19 pandemic. Endometriosis surgery is prohibited during the fourth, fifth, and sixth months of the COVID-19 pandemic, according to a study published in October 2021 titled "Endometriosis Surgery During the First Wave of the COVID-19 Pandemic: A Brazilian Single Institution Experience." Many endometriosis patients had postponed appointments, diagnostic tests, and elective therapeutic procedures. As a result, the decrease in endometrial surgeries during COVID-19 significantly impacted market growth. However, as endometrial surgeries resume and COVID-19 cases decline, the market is expected to return to pre-pandemic levels soon.
Recent Developments
- In 2022, CooperSurgical agreed to invest USD 875 million in Cook Medical's reproductive health portfolio, which includes fertility, obstetrics, gynaecology, and in vitro fertilization medical equipment.
- In 2022, Inovus Medical released HystAR, a new high-fidelity hysteroscopy simulator. The HystARTM is Inovus' third hysteroscopy simulator, joining the highly successful Bozzini Hysteroscopy line, which has been on the market for several years.
Global Endometrial Ablation Devices Market Scope
The endometrial ablation devices market is segmented on the basis of device type and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Device Type
- Hysteroscopy devices
- Thermal balloon ablators
- Radiofrequency endometrial ablation devices
- Hydrothermal ablators
- Electrical ablators
- Others
End-Use
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Others
Endometrial Ablation Devices Market Regional Analysis/Insights
The endometrial ablation devices market is analyzed and market size insights and trends are provided by country, device type and end-use as referenced above.
The countries covered in the endometrial ablation devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the endometrial ablation devices market due to increased prevalence of varicose veins, increased demand for minimally invasive treatment procedures.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the increased healthcare expenditure in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The endometrial ablation devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for endometrial ablation devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the endometrial ablation devices market. The data is available for historic period 2011-2021.
Competitive Landscape and Endometrial Ablation Devices Market Share Analysis
The endometrial ablation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to endometrial ablation devices market.
Some of the major players operating in the endometrial ablation devices market are:
- AEGEA Medical, Inc (U.S.)
- Boston Scientific Corporation (U.S.)
- CooperSurgical, Inc (U.S.)
- Hologic, Inc. (U.S.)
- IDOMAN-MED (Canada)
- Minerva Surgical, Inc (U.S.)
- Olympus Corporation (Japan)
- Omnitech Systems, Inc (U.S.)
- Medtronic (Ireland)
SKU-